AMAG Pharmaceuticals Provides Feraheme® Safety Update
LEXINGTON, Mass.—-AMAG Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today provided a safety update on Feraheme® Injection for intravenous use.
Read more on Business Wire via Yahoo! Finance
